ghk-cu hair growth study human clinical trial randomized controlled GHK Peptide (2016) — Research Summary ghk-cu hair growth randomized controlled – copper peptide ghk-cu hair growth

Age 18 is biologically fine

Rotation pattern: Alternate between the upper and lower portions of the LCL across injections

Medical Sciences

Intended Use This kit is designed exclusively for: Laboratory research In-vitro experimentation Biochemical pathway modeling Peptide-receptor interaction studies Non-human preclinical research Academic and institutional scientific work Not intended for: Human or animal use Injection, ingestion, inhalation, or topical administration Medical, therapeutic, diagnostic, or health-related purposes This compound is not approved by Health Canada, FDA, or any regulatory body for clinical application

The Bonferroni significance threshold was 1.79 10 3 (i.e., 0.05/28)

Leukocytes may release oxidants during phagocytosis that cause oxidative stress to the erythrocytes